Most Popular in:
New in Antiaging/Cosmeceuticals (page 4 of 68)
Mar 25, 2014 | 01:54 PM CDT
By: Joshua Hashim
Looking back at 2013 and ahead to trends in 2014, beauty ingredients are bringing more to the table, with vibrant color and hydrating options driving innovation.
Mar 25, 2014 | 09:21 AM CDT
Paraben and Formaldehyde Removal, in-cosmetics 2014 Launches, and More Beauty Ingredient News and Launches for Late March 2014
Get the latest news from TRI-K Industries, BASF, Merck, Impact Colors and more, as well as in-cosmetics 2014 launches from Croda, Dow, CareSil, Corbion Purac and Momentive.
Mar 24, 2014 | 04:39 PM CDT
By: Abby Penning
New innovations in beauty retailing utilize technology and touch, and help increase consumer-brand interactivity.
Mar 24, 2014 | 03:02 PM CDT
By: Abby Penning
A family tradition of truffles, botanical oils and beauty has helped build the base for great success for skin care brand Skin&Co Roma.
Mar 24, 2014 | 11:23 AM CDT
According to Euromonitor, consumer preoccupation with image and how they are perceived by others is another important trend somewhat attributed to the 'selfie.' This concern for one’s self-image means beauty companies will have to tailor to specific consumer needs with personalized and solution-based products.
Mar 24, 2014 | 11:14 AM CDT
Euromonitor shows how the growth in emerging markets in the beauty industry is pushing global beauty trends.
Mar 24, 2014 | 11:05 AM CDT
The completion of the sale is conditional upon the approval of the sale by the competition authorities.
Mar 20, 2014 | 10:09 AM CDT
Kosé, which recently acquired U.S.-based beauty brand Tarte, Inc., is also making plans to expand into the beauty market of India.
Mar 20, 2014 | 10:04 AM CDT
The purchase agreement was signed on March 19, 2014, with the buyer, the Deb Group of Denby, Great Britain.
Mar 20, 2014 | 10:00 AM CDT
As director of her own research clinic and private practice in laser and aesthetic dermatology in New York, Lancôme's new consulting dermatologist Dr. Macrene Renee Alexiades-Armenakas continuously examines the latest scientific literature to critically evaluate new molecules for their efficacy and safety.